Company Overview
Snapshot
Founded in December 2021 by Nikita Shenkar, Gaia Bio operates with 1–10 employees. The company has secured funding across three rounds from VentureIsrael, with its latest funding round occurring in September 2025.
Business overview
Gaia Bio specializes in industrial biotechnology, leveraging a novel gene-editing technology and proprietary methodology to enhance precision fermentation processes and improve bacterial bioremediation and biomining. The company's approach allows for the engineering of a broad spectrum of environmental bacteria, a critical capability for applications requiring bacteria to thrive in challenging conditions like acidic environments. Gaia Bio's technology aims to increase the yield of bacteria-based products and addresses complex environmental and sustainability challenges across various industries, including wastewater treatment, plastic remediation, alternative batteries, sustainable chemicals, metals recovery, and sustainable agriculture.
Log in to access full profile ›Company Intelligence Q&A
- When was Gaia Bio founded?
- Gaia Bio was founded in December 2021.
- Who is the founder of Gaia Bio?
- Nikita Shenkar is the Co-founder & CEO of Gaia Bio.
- What is Gaia Bio's primary sector?
- Gaia Bio's primary sector is Industrial Technologies.
- What is Gaia Bio's core technology?
- Gaia Bio focuses on using a new gene editing technology and proprietary methodology to increase yields in precision fermentation and enhance bacterial bioremediation and biomining processes.
- When did Gaia Bio receive its most recent funding?
- Gaia Bio received its most recent funding in September 2025, with VentureIsrael participating in the round.